Skip to main content
Top
Published in: Surgical Endoscopy 6/2020

01-06-2020 | Rectal Cancer | 2019 SAGES Oral

Robotic proctectomy for rectal cancer in the US: a skewed population

Authors: Asya Ofshteyn, Katherine Bingmer, Christopher W. Towe, Emily Steinhagen, Sharon L. Stein

Published in: Surgical Endoscopy | Issue 6/2020

Login to get access

Abstract

Background

Socioeconomic and racial differences have been associated with disparities in cancer care within the US, including disparate access to minimally invasive surgery for rectal cancer. We hypothesized that robotic approach to rectal cancer may be associated with similar disparities.

Methods

The National Cancer Database (NCDB) was used to identify patients over 18 years old with clinical stage I–III rectal adenocarcinoma who underwent a proctectomy between 2010 and 2014. Demographic and hospital factors were analyzed for association with robotic approach. Factors identified on bivariate analyses informed multivariate analysis.

Results

We identified 33,503 patients who met inclusion criteria; 3702 (11.1%) underwent robotic surgery with 7.8% conversion rate. Patients who received robotic surgery were more likely to be male, white, privately insured and with stage III cancer. They were also more likely to live in a metropolitan area, more than 25 miles away from the hospital and with a higher high school graduation rate. The treating hospital was more likely to be academic and high volume.

Conclusions

Robotic surgery is performed rarely and access to it is limited for patients who are female, black, older, non-privately insured and unable to travel to high-volume teaching institutions. The advantages of robotic surgery may not be available to all patients given disparate access to the robot. This inherent bias in access to robot may skew study populations, preventing generalizability of robotic surgery research.

Graphic abstract

Literature
10.
go back to reference Harrop E, Kelly J, Griffiths G, Casbard A, Nelson A, Published on behalf of the BOLERO Trial Management Group (TMG) P on behalf of the BTMG (2016) Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials 17:35. https://doi.org/10.1186/s13063-016-1173-z Harrop E, Kelly J, Griffiths G, Casbard A, Nelson A, Published on behalf of the BOLERO Trial Management Group (TMG) P on behalf of the BTMG (2016) Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials 17:35. https://​doi.​org/​10.​1186/​s13063-016-1173-z
Metadata
Title
Robotic proctectomy for rectal cancer in the US: a skewed population
Authors
Asya Ofshteyn
Katherine Bingmer
Christopher W. Towe
Emily Steinhagen
Sharon L. Stein
Publication date
01-06-2020
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 6/2020
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07041-0

Other articles of this Issue 6/2020

Surgical Endoscopy 6/2020 Go to the issue